SEC Form 4 · accession 0001179110-17-005327
Tvardi Therapeutics, Inc. · TVRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Joshua Ruch
10% Owner
Habib Kairouz
10% Owner
Mark Leschly
10% Owner
Rho Capital Partners LLC
10% Owner
RHO Ventures VI LP
10% Owner
RMV VI, L.L.C.
10% Owner
Period of report
Mar 31, 2017
Accepted (ET)
Apr 3, 2017 · 9:19 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001346830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 31, 2017 | P | 500,000 | $18.1914 | A | 3,568,057 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities are owned directly by Rho Ventures VI, L.P. ("RV VI"). RMV VI, L.L.C. ("RMV") is the general partner of RV VI and Rho Capital Partners LLC ("RCP") is the managing member of RMV. Mark Leschly, Habib Kairouz and Joshua Ruch are managing members of RCP and exercise shared voting and investment power with respect to the shares owned by RV VI. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his or its respective pecuniary interest therein.